Karas Kevin R 4

4 · NATIONAL RESEARCH CORP · Filed Mar 25, 2021

Form 4

Period: 2018-09-24

SVP Finance, CFO, Treas & Secy

Transactions

Exercise/Conversion
Common Stock
2021-03-23$18.80/sh+5,334$100,279→ 15,718 total
Exercise/Conversion
Common Stock
2021-03-23$13.17/sh+19,313$254,352→ 35,031 total
Tax Payment
Common Stock
2021-03-23$45.55/sh−12,735$580,079→ 22,296 total
Sale
Common Stock
2018-09-24$38.23/sh−3,700$141,446→ 10,684 total
Sale
Common Stock
2018-09-24$39.06/sh−300$11,717→ 10,384 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-03-23−5,334→ 0 total
Exercise: $18.80Exp: 2024-01-07→ Common Stock (5,334 underlying)
Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-03-23−19,313→ 0 total
Exercise: $13.17Exp: 2025-01-06→ Common Stock (19,313 underlying)

Footnotes (4)

[F1]The price in Column 4 is a weighted average. The prices actually ranged from $38.00 to $38.70, inclusive. The reporting person has provided the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1) and (2) of this Form 4.
[F2]The price in Column 4 is a weighted average price. The prices actually ranged from $39.025 to $39.075, inclusive.
[F3]This option became fully exercisable on January 7, 2019.
[F4]This option became fully exercisable on January 6, 2020.

Documents

1 file